Literature DB >> 3097133

Interleukin 2 induction of interferon-gamma mRNA synthesis.

W L Farrar, M C Birchenall-Sparks, H B Young.   

Abstract

Interleukin 2 (IL 2) induces specific mRNA synthesis and secretion of an important immunoregulatory molecule, interferon-gamma (IFN-gamma). We have observed that treatment of an IL 2 independent murine T cell line, BUD-27, with IL 2, calcium ionophore A23187, or agents that activate phospholipid/Ca2+-dependent protein kinase C results in increased IFN-gamma mRNA transcription and release of anti-viral activity. These same agents each induced the subcellular redistribution of protein kinase C from cytosol to plasma membrane in both the BUD-27 cell line and its IL 2-dependent parent, CT6. Ionophore concentrations greater than 1 micron exhibited the most significant induction of IFN-gamma mRNA, which also correlated with the dose of ionophore, inducing translocation of protein kinase C. This correlation between increased mRNA levels and protein kinase C translocation suggests that a calcium-dependent event is involved in induction of IFN-gamma mRNA synthesis. Furthermore, the magnitude of the translocation of protein kinase C from cytosol to plasma membrane corresponded to the physiologic IL 2 dose-response for IFN-gamma secretion. The data suggest that the activation of protein kinase C and/or coordinate elevation of intracellular calcium may provide at least one mechanism of signal transduction for the regulation of IFN-gamma gene transcription.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3097133

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

Review 1.  Polypeptides controlling hematopoietic cell development and activation. I. In vitro results.

Authors:  F Herrmann; R Mertelsmann
Journal:  Blut       Date:  1989-03

Review 2.  An assessment of phosphoinositide hydrolysis in antigenic signal transduction in lymphocytes.

Authors:  S L King
Journal:  Immunology       Date:  1988-09       Impact factor: 7.397

3.  Deficiency of interleukin-2 activity upon addition of soluble egg antigen to cultures of spleen cells from mice infected with Schistosoma japonicum.

Authors:  A B Stavitsky; W W Harold
Journal:  Infect Immun       Date:  1988-07       Impact factor: 3.441

Review 4.  Interferons and indoleamine 2,3-dioxygenase: role in antimicrobial and antitumor effects.

Authors:  J M Carlin; Y Ozaki; G I Byrne; R R Brown; E C Borden
Journal:  Experientia       Date:  1989-06-15

5.  Release of cytokines during generation of lymphokine-activated killer (LAK) cells by IL-2.

Authors:  G A Limb; A Meager; J Woolley; M Wadhwa; J Biggerstaff; K A Brown; R A Wolstencroft
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

6.  Defective macrophage antigen presentation following haemorrhage is associated with the loss of MHC class II (Ia) antigens.

Authors:  A Ayala; M M Perrin; I H Chaudry
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

7.  The CySF-L2 factor from dialysable human leucocyte extract activates natural killer cytotoxicity by induction of interferon gamma.

Authors:  I Doelker; F A Anderer
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

8.  High frequency of spontaneous interferon-gamma-producing cells in human tonsils: role of local accessory cells and soluble factors.

Authors:  M Quiding; G Granström; I Nordström; B Ferrua; J Holmgren; C Czerkinsky
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

9.  Mechanism of stimulation of human natural killer cytotoxicity by arabinogalactan from Larix occidentalis.

Authors:  J Hauer; F A Anderer
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

10.  Role of N-glycosylation in the synthesis, dimerization and secretion of human interferon-gamma.

Authors:  T Sareneva; J Pirhonen; K Cantell; N Kalkkinen; I Julkunen
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.